NASDAQ:FDMT

4d Molecular Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy FDMT

*Your capital is at risk

$9.53

+0.260 (+2.80%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

FDMT Prediction Chart

FDMT Predictions History

Latest community submissions for FDMT.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
23tmarks.260419	Oct 5, 2021	Bullish	$26.04	X	—	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for FDMT with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT 4D MOLECULAR THERAPEUTICS, INC.

4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical trials: 4D-125 that is in a Phase 1/2 clinical trial for the treatment of X-linked retinitis pigmentosa; ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by